TCF4 and thyroid gland carcinoma: EGFEM1P was also reported to be upregulated in papillary thyroid tumors and thyroid cancer cells compared with normal adjacent tissues, and promoted thyroid cancer progression by acting as an miR-369-3p sponge and upregulation TCF4 (Yi et al., 2022).